Both in Pharmaceuticals
Greenwich LifeSciences vs Standard BioTools
Over the past year GLSI returned +60.5% and LAB returned −57.4%; their daily moves had a correlation of 0.10.
GLSI +60.5% LAB −57.4%Growth of $1, one year, split-adjusted
| Metric | GLSI | LAB |
|---|---|---|
| Price | $16.03 | $0.6056 |
| Market cap | $235.3M | $239.0M |
| Today | +3.55% | −4.72% |
| 1 month | −11.4% | −18.5% |
| 6 months | −33.8% | −32.7% |
| Year to date | −23.7% | −52.7% |
| 1 year | +76.9% | −54.1% |
| Revenue growth (YoY) | — | −7.6% |
| Gross margin | — | 52.4% |
| Net margin | — | −133.1% |
| P/E (TTM) | — | 2.8× |
| Price / sales | — | 2.8× |
| Net cash | $8.9M | $476.4M |
| Dividend yield | — | — |
| Volatility (60d) | 89.6% | 47.4% |
| Short % of float | 24.9% | 1.1% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).